PTC Therapeutics, Inc. (PTCT)
69.45
-1.25
(-1.77%)
USD |
NASDAQ |
Feb 13, 16:00
69.39
-0.06
(-0.09%)
After-Hours: 20:00
PTC Therapeutics Free Cash Flow : 446.25M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| BioMarin Pharmaceutical, Inc. | 825.79M |
| Sarepta Therapeutics, Inc. | -401.63M |
| Spyre Therapeutics, Inc. | -162.30M |
| Keros Therapeutics, Inc. | 87.08M |
| ACADIA Pharmaceuticals, Inc. | 98.97M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -66.30M |
| Cash from Investing (Quarterly) | -289.62M |
| Cash from Financing (Quarterly) | 15.22M |
| Free Cash Flow Per Share (Quarterly) | -3.702 |
| Free Cash Flow to Equity (Quarterly) | -344.46M |
| Free Cash Flow to Firm (Quarterly) | -344.95M |
| Free Cash Flow Yield | 7.82% |